Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Neuromuscular

Original research

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

	Abstract	Full	Pdf
Jun 2021	1385	1387	294
Jul 2021	446	447	173
Aug 2021	299	294	93
Sep 2021	838	845	211
Oct 2021	387	392	141
Nov 2021	214	212	107
Dec 2021	172	183	63
Jan 2022	204	208	64
Feb 2022	193	206	55
Mar 2022	219	227	65
Apr 2022	204	203	45
May 2022	207	213	48
Jun 2022	155	154	47
Jul 2022	205	205	38
Aug 2022	240	245	44
Sep 2022	218	222	52
Oct 2022	258	260	59
Nov 2022	261	266	46
Dec 2022	221	221	44
Jan 2023	253	257	54
Feb 2023	228	230	41
Mar 2023	247	253	61
Apr 2023	183	185	35
May 2023	145	146	43
Jun 2023	191	180	28
Jul 2023	197	199	30
Aug 2023	204	200	29
Sep 2023	182	184	29
Oct 2023	235	239	36
Nov 2023	279	281	37
Dec 2023	210	204	46
Jan 2024	120	90	21
Feb 2024	155	151	35
Mar 2024	270	251	93
Total	9425	9440	2307